News | July 27, 2008

New Family of Neurovascular Retrievers Launched by Concentric Medical

July 28, 2008 - Concentric Medical Inc. today said it launched its “V” series of Merci Retrievers, available in multiple configurations and sizes to match patient anatomy to remove blood clots and help restore blood flow in patients who have suffered ischemic strokes.

The distal end of the latest Retriever is tightly coiled, which resists stretching and assists in dislodging clots. The proximal end of the V series retrievers is more loosely coiled, which facilitates wrapping and holding a dislodged clot. Similar to Concentric Medical’s L family of retrievers, the V series of Merci Retrievers incorporate filaments that provide an additional mechanism for securing blood clots during retrieval from the brain, the company said. The V series of Merci Retrievers will be available in diameters of 2.0, 2.5 and 3.0 millimeters.

The Merci Retriever is made with a flexible, shaped Nitinol wire that allows delivery of the retriever in linear form using standard catheterization techniques. A neurointerventionalist makes a small puncture in the groin to introduce the Merci Retriever into an artery leading to the brain. The Merci Retriever returns to its original shape when deployed in and around the blood clot in the brain.

For more information: www.concentric-medical.com

Related Content

New Stroke Training Model Improves Access to Life-Saving Care
News | Stroke | March 27, 2019
Training interventional radiologists to perform endovascular thrombectomies results in positive outcomes for patients...
Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research
News | Stroke | March 19, 2019
iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research...
Corindus Seeking Neurovascular Intervention Clearance for CorPath GRX Vascular Robotic System
News | Stroke | February 15, 2019
Corindus Vascular Robotics Inc. is seeking premarket clearance from the U.S. Food and Drug Administration (FDA) to use...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
Medication Alone May Not Eliminate Stroke Risk in Carotid Atherosclerotic Stenosis Patients
News | Stroke | October 31, 2018
Recent statin and medication advances have led some researchers to suggest surgical treatments for carotid stenosis...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Stroke | August 28, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...
Breast feeding may help reduce the stroke risk in women. Katherine Fornell

Breast feeding may help reduce the stroke risk in women.

News | Stroke | August 22, 2018
Breastfeeding is not only good for babies, according to new research in the Journal of the American Heart Association....
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
July 13, 2018 – iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAP
NewYork-Presbyterian Expands Mobile Stroke Treatment Unit Fleet
News | Stroke | June 11, 2018
NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the...
Overlay Init